Literature DB >> 16618340

Trigger point evaluation in migraine patients: an indication of peripheral sensitization linked to migraine predisposition?

E P Calandre1, J Hidalgo, J M García-Leiva, F Rico-Villademoros.   

Abstract

Although migraine is a neurovascular disorder, both scalp tenderness and referred pain have been observed in migraine patients. The present study was carried out to investigate the presence of trigger points eliciting referred pain in 98 migraine patients and in 32 healthy subjects. Trigger points were found in 92 (93.9%) migraineurs and in nine (29%) controls (P < 0.0001). The number of individual migraine trigger points varied from zero to 14 (modal number: 4), and was found to be related to both the frequency of migraine attacks (P < 0.0001), and the duration of the disease (P = 0.017). About 74% of the total detected trigger points were found in temporal and/or suboccipital areas; other locations were mainly found in patients showing more than four trigger points. Trigger point palpation provoked a migraine attack in 30 (30.6%) patients. Pericraneal allodynia was found in 15 (15.3%) patients. These data indicate that nociceptive peripheral sensitization is a usual finding in migraine, and that central sensitization can develop in patients with frequent attacks and long-lasting disease. Trigger points' detection in migraine patients could be useful when applying therapies like acupuncture, needling or botulinum toxin injections directed to reduce peripheral sensitization.

Entities:  

Mesh:

Year:  2006        PMID: 16618340     DOI: 10.1111/j.1468-1331.2006.01181.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  26 in total

1.  Painful scalp arteries in migraine.

Authors:  Carlo Cianchetti; Maria Giuseppina Ledda; Maria Celeste Serci; Francesco Madeddu
Journal:  J Neurol       Date:  2010-05-09       Impact factor: 4.849

2.  Dry needling for the management of thoracic spine pain.

Authors:  César Fernández-de-Las-Peñas; Michelle Layton; Jan Dommerholt
Journal:  J Man Manip Ther       Date:  2015-07

Review 3.  Myofascial Head Pain.

Authors:  César Fernández-de-Las-Peñas
Journal:  Curr Pain Headache Rep       Date:  2015-07

4.  Chronic daily headache: suggestion for the neuromuscular oral therapy.

Authors:  H Didier; C Marchetti; G Borromeo; V Tullo; D D'amico; G Bussone; F Santoro
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

5.  Novel applications of ultrasound technology to visualize and characterize myofascial trigger points and surrounding soft tissue.

Authors:  Siddhartha Sikdar; Jay P Shah; Tadesse Gebreab; Ru-Huey Yen; Elizabeth Gilliams; Jerome Danoff; Lynn H Gerber
Journal:  Arch Phys Med Rehabil       Date:  2009-11       Impact factor: 3.966

6.  Dry needling - peripheral and central considerations.

Authors:  Jan Dommerholt
Journal:  J Man Manip Ther       Date:  2011-11

Review 7.  The role of myofascial trigger points in musculoskeletal pain syndromes of the head and neck.

Authors:  César Fernández-de-Las-Peñas; David Simons; Maria Luz Cuadrado; Juan Pareja
Journal:  Curr Pain Headache Rep       Date:  2007-10

8.  A pilot study to investigate the short-term effects of specific soft tissue massage on upper cervical movement impairment in patients with cervicogenic headache.

Authors:  Diana Hopper; Yogita Bajaj; Chor Kei Choi; Osama Jan; Toby Hall; Kim Robinson; Kathy Briffa
Journal:  J Man Manip Ther       Date:  2013-02

9.  Inhibitory effect of high-frequency greater occipital nerve electrical stimulation on trigeminovascular nociceptive processing in rats.

Authors:  Olga A Lyubashina; Sergey S Panteleev; Alexey Y Sokolov
Journal:  J Neural Transm (Vienna)       Date:  2016-09-27       Impact factor: 3.575

10.  Myofascial trigger points in cluster headache patients: a case series.

Authors:  Elena P Calandre; Javier Hidalgo; Juan M Garcia-Leiva; Fernando Rico-Villademoros; Antonia Delgado-Rodriguez
Journal:  Head Face Med       Date:  2008-12-30       Impact factor: 2.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.